A citation-based method for searching scientific literature

Jiahui Wu, Xiang Chen, Qianyi Bao, Rui Duan, Yucui Jin, Yifang Shui, Bing Yao, Xiangdong Lu, Yue Wang, Hongyan Cui, Lingyun Li, Hongyan Yuan, Changyan Ma. Cell Physiol Biochem 2017
Times Cited: 4







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


EFEMP2 Mediates GALNT14-Dependent Breast Cancer Cell Invasion.
Tao Zuo, Jinshuai Shan, Yang Liu, Rong Xie, Xiaochun Yu, Chen Wu. Transl Oncol 2018
9
50

Upregulated osterix promotes invasion and bone metastasis and predicts for a poor prognosis in breast cancer.
Bing Yao, Jue Wang, Shuang Qu, Yang Liu, Yuci Jin, Jianlei Lu, Qianyi Bao, Lingyun Li, Hongyan Yuan, Changyan Ma. Cell Death Dis 2019
15
50


MiR-483-3p regulates oxaliplatin resistance by targeting FAM171B in human colorectal cancer cells.
Hui Liang, Yisong Xu, Qiang Zhang, Yu Yang, Yueyang Mou, Yingchun Gao, Rui Chen, Chao Chen, Penggao Dai. Artif Cells Nanomed Biotechnol 2019
20
25



IDEG6: a web tool for detection of differentially expressed genes in multiple tag sampling experiments.
Chiara Romualdi, Stefania Bortoluzzi, Fabio D'Alessi, Gian Antonio Danieli. Physiol Genomics 2003
263
25

Global cancer statistics.
Ahmedin Jemal, Freddie Bray, Melissa M Center, Jacques Ferlay, Elizabeth Ward, David Forman. CA Cancer J Clin 2011
25


The PI3K/AKT Pathway as a Target for Cancer Treatment.
Ingrid A Mayer, Carlos L Arteaga. Annu Rev Med 2016
428
25

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.
Zefang Tang, Chenwei Li, Boxi Kang, Ge Gao, Cheng Li, Zemin Zhang. Nucleic Acids Res 2017
25

SNHG14 confers gefitinib resistance in non-small cell lung cancer by up-regulating ABCB1 via sponging miR-206-3p.
Kai Wu, Jiachen Li, Yu Qi, Chunyang Zhang, Dengyan Zhu, Donglei Liu, Song Zhao. Biomed Pharmacother 2019
14
25


Mechanisms of Taxol resistance related to microtubules.
George A Orr, Pascal Verdier-Pinard, Hayley McDaid, Susan Band Horwitz. Oncogene 2003
497
25

A novel cytogenetic and molecular characterization of renal metanephric adenoma: Identification of partner genes involved in translocation t(9;15)(p24;q24).
Aida Catic, Amina Kurtovic-Kozaric, Sarah H Johnson, George Vasmatzis, Michael R Pins, Jillene Kogan. Cancer Genet 2017
5
25



Epigenetics in cancer stem cells.
Tan Boon Toh, Jhin Jieh Lim, Edward Kai-Hua Chow. Mol Cancer 2017
141
25


Erythrocyte fatty acids as potential biomarkers in the diagnosis of advanced lung adenocarcinoma, lung squamous cell carcinoma, and small cell lung cancer.
Javier de Castro, Marina C Rodríguez, Vicenta S Martínez-Zorzano, Patricia Sánchez-Rodríguez, Jesús Sánchez-Yagüe. Am J Clin Pathol 2014
16
25

KANK1, a candidate tumor suppressor gene, is fused to PDGFRB in an imatinib-responsive myeloid neoplasm with severe thrombocythemia.
S Medves, F P Duhoux, A Ferrant, F Toffalini, G Ameye, J-M Libouton, H A Poirel, J-B Demoulin. Leukemia 2010
28
25

Wee1B is an oocyte-specific kinase involved in the control of meiotic arrest in the mouse.
Seung Jin Han, Ruby Chen, Maria Paola Paronetto, Marco Conti. Curr Biol 2005
146
25

Epigenetic modifications and human disease.
Anna Portela, Manel Esteller. Nat Biotechnol 2010
25

Depletion of tumor suppressor Kank1 induces centrosomal amplification via hyperactivation of RhoA.
Jun-Ichiro Suzuki, Badal Chandra Roy, Takunori Ogaeri, Naoto Kakinuma, Ryoiti Kiyama. Exp Cell Res 2017
4
25

Kank1 reexpression induced by 5-Aza-2'-deoxycytidine suppresses nasopharyngeal carcinoma cell proliferation and promotes apoptosis.
Fan-Yan Luo, Shan Xiao, Zi-Hou Liu, Peng-Fei Zhang, Zhi-Qiang Xiao, Can-E Tang. Int J Clin Exp Pathol 2015
7
25

Dishevelled 1, a pivotal positive regulator of the Wnt signalling pathway, mediates 5-fluorouracil resistance in HepG2 cells.
Yisong Xu, Cheng Zhang, Hui Liang, Shanshuang Hu, Pengkun Li, Linna Liu, Xianglong Duan, Chao Chen, Yani Zhang, Penggao Dai. Artif Cells Nanomed Biotechnol 2018
9
25

Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer.
Jean-Charles Soria, Zsuzsanna Márk, Petr Zatloukal, Barna Szima, István Albert, Erzsébet Juhász, Jean-Louis Pujol, Jerzy Kozielski, Nigel Baker, Dominic Smethurst,[...]. J Clin Oncol 2011
174
25

KANK1 inhibits cell growth by inducing apoptosis through regulating CXXC5 in human malignant peripheral nerve sheath tumors.
Zhibin Cui, Yingjia Shen, Kenny H Chen, Suresh K Mittal, Jer-Yen Yang, GuangJun Zhang. Sci Rep 2017
15
25

Unraveling the genetics of cancer: genome sequencing and beyond.
Kit Man Wong, Thomas J Hudson, John D McPherson. Annu Rev Genomics Hum Genet 2011
65
25

DNA methylation and the preservation of cell identity.
Ozren Bogdanović, Ryan Lister. Curr Opin Genet Dev 2017
52
25

LRG1 suppresses the migration and invasion of hepatocellular carcinoma cells.
Yurong Zhang, Qin Luo, Ning Wang, Fangyuan Hu, Haojie Jin, Tianxiang Ge, Cun Wang, Wenxin Qin. Med Oncol 2015
17
25

Aldh3a1 protects human corneal epithelial cells from ultraviolet- and 4-hydroxy-2-nonenal-induced oxidative damage.
Aglaia Pappa, Chunhe Chen, Yiannis Koutalos, Alan J Townsend, Vasilis Vasiliou. Free Radic Biol Med 2003
87
25

CXCL12 methylation-mediated epigenetic regulation of gene expression in papillary thyroid carcinoma.
Sijia Zhang, Yihan Wang, Meijun Chen, Lulu Sun, Jun Han, V Kazakova Elena, Hong Qiao. Sci Rep 2017
23
25

The promise of epigenetic therapy: reprogramming the cancer epigenome.
Andrew D Kelly, Jean-Pierre J Issa. Curr Opin Genet Dev 2017
88
25

Mechanisms of cancer drug resistance.
Michael M Gottesman. Annu Rev Med 2002
25

The biology and management of non-small cell lung cancer.
Roy S Herbst, Daniel Morgensztern, Chris Boshoff. Nature 2018
25

MEK-ERK-dependent multiple caspase activation by mitochondrial proapoptotic Bcl-2 family proteins is essential for heavy ion irradiation-induced glioma cell death.
A Tomiyama, K Tachibana, K Suzuki, S Seino, J Sunayama, K-i Matsuda, A Sato, Y Matsumoto, T Nomiya, K Nemoto,[...]. Cell Death Dis 2010
34
25

Genetic heterogeneity and cancer drug resistance.
Nicholas C Turner, Jorge S Reis-Filho. Lancet Oncol 2012
285
25

Prognostic Stratification of Advanced Gastric Signet Ring Cell Carcinoma by Clinicopathological Factors and GALNT14 Genotype.
Tsung-Hsing Chen, Wey-Ran Lin, Chieh Lee, Cheng-Tang Chiu, Jun-Te Hsu, Ta-Sen Yeh, Kwang-Huei Lin, Puo-Hsien Le, Chau-Ting Yeh. J Cancer 2018
7
25

GALNT14 mediates tumor invasion and migration in breast cancer cell MCF-7.
Tian Huanna, Zuo Tao, Wang Xiangfei, An Longfei, Xie Yuanyuan, Wang Jianhua, Zhang Cuifang, Jiao Manjing, Cao Wenjing, Qin Shaochuan,[...]. Mol Carcinog 2015
44
25



GALNT14 Involves the Regulation of Multidrug Resistance in Breast Cancer Cells.
Jinshuai Shan, Yang Liu, Yukun Wang, Yimiao Li, Xiaochun Yu, Chen Wu. Transl Oncol 2018
4
25

A GALNT14 rs9679162 genotype-guided therapeutic strategy for advanced hepatocellular carcinoma: systemic or hepatic arterial infusion chemotherapy.
Chen-Chun Lin, Chao-Wei Hsu, Yi-Cheng Chen, Ming-Ling Chang, Kung-Hao Liang, Ming-Wei Lai, Chih-Lang Lin, Rong-Nan Chien, Kwang-Huei Lin, Chau-Ting Yeh. Pharmacogenomics J 2020
2
50


GALNT14 genotype as a response predictor for concurrent chemoradiotherapy in advanced esophageal squamous cell carcinoma.
Yung-Kuan Tsou, Kung-Hao Liang, Wey-Ran Lin, Hsien-Kun Chang, Chen-Kan Tseng, Chau-Ting Yeh. Oncotarget 2017
10
25

Mucin-type O-glycosylation and its potential use in drug and vaccine development.
Mads Agervig Tarp, Henrik Clausen. Biochim Biophys Acta 2008
209
25

Advances in pancreatic cancer biomarkers.
Syed Hasan, Rojymon Jacob, Upender Manne, Ravi Paluri. Oncol Rev 2019
40
25


GalNAc-T14 promotes metastasis through Wnt dependent HOXB9 expression in lung adenocarcinoma.
Ok-Seon Kwon, Ensel Oh, Jeong-Rak Park, Ji-Seon Lee, Gab-Yong Bae, Jae-Hyung Koo, Hyongbum Kim, Yoon L Choi, Young Soo Choi, Jhingook Kim,[...]. Oncotarget 2015
20
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.